“I just wanted to speak to someone- and there was no one…”: using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipients

BACKGROUND: Advanced therapy medicinal products such as Chimeric antigen receptor T-cell therapy offer ground-breaking opportunities for the treatment of various cancers, inherited diseases, and chronic conditions. With development of these novel therapies continuing to increase it’s important to le...

Descripción completa

Detalles Bibliográficos
Autores principales: Litchfield, Ian, Calvert, Melanie J., Kinsella, Francesca, Sungum, Nisha, Aiyegbusi, Olalekan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111696/
https://www.ncbi.nlm.nih.gov/pubmed/37069697
http://dx.doi.org/10.1186/s13023-023-02680-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111696/
https://www.ncbi.nlm.nih.gov/pubmed/37069697
http://dx.doi.org/10.1186/s13023-023-02680-y

Ejemplares similares